TrialWorld journal of gastroenterology2007

Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B.

Paolo Del Poggio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.